Alzheimer’s Drug Discovery Foundation: Accelerating Discovery for Frontotemporal Degeneration

The Alzheimer’s Drug Discovery Foundation (ADDF), in collaboration with the Association for Frontotemporal Degeneration (AFTD) is accepting Letters of Intent (LOIs) to support research to accelerate and support innovative drug discovery programs for FTD. Award amount up to $150,000 for one (1) year. The LOI deadline is July 31, 2017 by 11:59pm EST.

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Alzheimer's Drug Discovery Foundation: Accelerating Discovery for Frontotemporal Degeneration
http://www.alzdiscovery.org

The Alzheimer’s Drug Discovery Foundation (ADDF), in collaboration with the Association for Frontotemporal Degeneration (AFTD) is accepting Letters of Intent (LOIs) to support research to accelerate and support innovative drug discovery programs for FTD. ADDF’s research priority areas include:

  • Development and testing of novel high throughput screening assays
  • Identification and in vitro testing of potentially disease modifying compounds or biologics, including medicinal chemistry refinement, ADME, toxicology, pharmacokinetics, and pharmacodynamics studies
  • Testing of novel lead compounds, biologics, or repurposed drug candidates in a relevant animal model for preclinical proof of concept
  • Development and/or characterization of new model organisms or cellular models to support drug discovery efforts

The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $100,000-$150,000 per year for a preclinical project depending on the stage of research and must be justified based on the scientific work plan. Applications will be confidentially reviewed by the ADDF and an external Scientific Review Committee, including members of AFTD's Medical Advisory Council.

LOI Deadline: July 31, 2017 by 11:59pm EST. Invited full proposals due September 8, 2017. Application Guidelines for the award: https://www.alzdiscovery.org/research-and-grants/funding-opportunities/accelerating-drug-discovery-for-ftd.

The UNC Office of Corporate and Foundation Relations is available to provide assistance to UNC personnel in pursuing privately funded opportunities. If you have any questions about this funding opportunity, please email cfr@unc.edu or phone 919.962.2867.